 |
|
|
| | Monday, February 28, 2022 |
|
|
|
| 12:00 p.m. |
|
Other Tri-Institutional Events
Structural Insights into Nucleases in Proofreading Coronavirus Replication and Driving the Diversity of Host Adaptive Immunity
Structural Biology Special Seminar
Chang Liu, Ph.D., postdoctoral associate, Yale University School of Medicine
|
| 1:30 p.m. |
|
Other Tri-Institutional Events
Harnessing Innate Immunity in Cancer Therapies: The Example of Natural Killer Cell Engagers
Immunology and Microbial Pathogenesis Program Research Seminar Series
Eric Vivier, M.D., Ph.D., chief science officer, senior vice president, Innate Pharma; professor of immunology, Aix-Marseille University
|
| 6:30 p.m. |
|
Club Meetings
How Narratives of Racial Progress Create Barriers to Diversity, Equity, and Inclusion in Organizations
RiSI Diversity, Equity, Inclusion, and Justice Journal Club
|
|
| | Tuesday, March 1, 2022 |
|
|
|
| 4:00 p.m. |
|
Molecular Pharmacology and Chemistry Program
Cross-talks of Phosphorylation on RNA Polymerase II Guarantee Accurate Transcription
Jessie (Yan) Zhang, Ph.D., professor, University of Texas
|
